Pharmaron Beijing Co., Ltd. (3759.HK)
3759.HK Stock Price Chart
Explore Pharmaron Beijing Co., Ltd. interactive price chart. Choose custom timeframes to analyze 3759.HK price movements and trends.
3759.HK Company Profile
Discover essential business fundamentals and corporate details for Pharmaron Beijing Co., Ltd. (3759.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
28 Nov 2019
Employees
21.37K
Website
https://www.pharmaron.comCEO
Boliang Lou
Description
Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides pharmaceutical research and development services to the life sciences industry in North America, Europe, Mainland China, rest of Asia, and internationally. The company operates through five segments: Laboratory Services; Chemistry, Manufacturing and Controls (CMC) Services; Clinical Development Services; Biologics and Cell and Gene Therapy Services; and Others. It offers laboratory chemistry solutions, including medicinal, synthetic, and analytical and purification chemistry, as well as computer-aided drug design services; bioscience services comprising in vitro and in vivo drug metabolism and pharmacokinetics/absorption, distribution, metabolism, and excretion solutions; and in vitro biology and in vivo pharmacology, safety assessment, and the U.S. laboratory services. The company also provides process development and manufacturing, material science/pre-formulation, formulation development and manufacturing, and analytical development services; and radiolabelled science services and early stage clinical trial services, as well as clinical research and site management services. It also provides business development; and contract research, development, and manufacturing services for pharmaceutical products. The company was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
3759.HK Financial Timeline
Browse a chronological timeline of Pharmaron Beijing Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 25 Apr 2026
Upcoming earnings on 26 Mar 2026
Upcoming earnings on 30 Oct 2025
EPS estimate is $0.25, while revenue estimate is $3.56B.
Earnings released on 21 Aug 2025
EPS came in at $0.24 falling short of the estimated $0.25 by -4.24%, while revenue for the quarter reached $3.64B , beating expectations by +2.82%.
Dividend declared on 4 Jul 2025
A dividend of $0.22 per share was announced, adjusted to $0.22. The dividend was paid on 6 Aug 2025.
Earnings released on 27 Apr 2025
EPS came in at $0.18 falling short of the estimated $0.24 by -24.38%, while revenue for the quarter reached $3.31B , missing expectations by -0.88%.
Earnings released on 25 Mar 2025
EPS came in at $0.22 falling short of the estimated $0.25 by -10.04%, while revenue for the quarter reached $3.68B , beating expectations by +12.34%.
Earnings released on 29 Oct 2024
EPS came in at $0.18 falling short of the estimated $0.22 by -18.18%, while revenue for the quarter reached $3.56B , missing expectations by -3.44%.
Earnings released on 28 Aug 2024
EPS came in at $0.50 surpassing the estimated $0.34 by +47.06%, while revenue for the quarter reached $3.15B , missing expectations by -9.77%.
Dividend declared on 27 Jun 2024
A dividend of $0.24 per share was announced, adjusted to $0.24. The dividend was paid on 26 Jul 2024.
Dividend declared on 27 Jun 2024
A dividend of $0.22 per share was announced, adjusted to $0.22. The dividend was paid on 26 Jul 2024.
Earnings released on 26 Apr 2024
EPS came in at $0.14 falling short of the estimated $0.35 by -60.11%, while revenue for the quarter reached $2.89B , missing expectations by -26.44%.
Earnings released on 28 Mar 2024
EPS came in at $0.27 falling short of the estimated $0.35 by -24.11%, while revenue for the quarter reached $3.30B , missing expectations by -16.39%.
Earnings released on 30 Sept 2023
EPS came in at $0.21 falling short of the estimated $0.29 by -26.03%, while revenue for the quarter reached $3.13B , missing expectations by -9.93%.
Dividend declared on 18 Jul 2023
A dividend of $0.33 per share was announced, adjusted to $0.33. The dividend was paid on 18 Aug 2023.
Stock split effective on 18 Jul 2023
Shares were split 3 : 2 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Jun 2023
EPS came in at $0.27 surpassing the estimated $0.26 by +1.57%, while revenue for the quarter reached $3.15B , missing expectations by -0.70%.
Earnings released on 31 Mar 2023
EPS came in at $0.22 surpassing the estimated $0.19 by +21.01%, while revenue for the quarter reached $3.11B , missing expectations by -6.33%.
Earnings released on 1 Jan 2023
EPS came in at $0.26 , while revenue for the quarter reached $3.17B .
Earnings released on 30 Sept 2022
EPS came in at $0.23 falling short of the estimated $0.33 by -28.86%, while revenue for the quarter reached $3.04B , missing expectations by -2.33%.
Earnings released on 30 Jun 2022
EPS came in at $0.22 surpassing the estimated $0.16 by +42.33%, while revenue for the quarter reached $2.96B , beating expectations by +2.12%.
Dividend declared on 6 Jun 2022
A dividend of $0.53 per share was announced, adjusted to $0.35. The dividend was paid on 12 Jul 2022.
Stock split effective on 6 Jun 2022
Shares were split 3 : 2 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Mar 2022
EPS came in at $0.17 falling short of the estimated $0.22 by -22.99%, while revenue for the quarter reached $2.59B .
Earnings released on 31 Dec 2021
EPS came in at $0.43 , while revenue for the quarter reached $2.62B .
Earnings released on 30 Sept 2021
EPS came in at $0.32 falling short of the estimated $0.43 by -24.68%, while revenue for the quarter reached $2.43B , missing expectations by -8.43%.
Earnings released on 30 Jun 2021
EPS came in at $0.22 , while revenue for the quarter reached $2.16B .
Dividend declared on 1 Jun 2021
A dividend of $0.36 per share was announced, adjusted to $0.16. The dividend was paid on 15 Jul 2021.
Earnings released on 31 Mar 2021
EPS came in at $0.16 , while revenue for the quarter reached $1.76B .
Earnings released on 31 Dec 2020
EPS came in at $0.25 , while revenue for the quarter reached $1.84B .
Earnings released on 30 Sept 2020
EPS came in at $0.20 , while revenue for the quarter reached $1.59B .
3759.HK Stock Performance
Access detailed 3759.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.